findmyKOL

Bruce Zagelbaum, MD

Basic profile

Hofstra University

ORCIDNone on fileNPI
RegionHicksville, NY · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Bruce Zagelbaum is an Ophthalmology physician affiliated with Hofstra University. OpenAlex indexes 32 publications with 378 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
32publications

Distinct works indexed by OpenAlex.

378citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

360 S Oyster Bay Rd
Hicksville, NY 118013508

Telephone

516-938-6363

Registry record last updated 8 Jan 2019.

View the NPPES registry record

Industry payments

11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    82.9%
    Prostaglandin Analog39.2%
    Latanoprost86%Lumigan10%Travoprost2%Iyuzeh2%
    Part D<11 patients
    Carbonic Anhydrase Inhibitor12.8%
    Dorzolamide-Timolol77%Dorzolamide Hcl16%Simbrinza7%
    Part D<11 patients

    + 8 more classes in this area

  • Cardiovascular

    11.8%
    Beta blocker11.8%
    Timolol Maleate95%Betoptic S5%
    Part D<11 patients
  • Anti-infectives

    3.8%
    Fluoroquinolone Antibacterial1.7%
    Moxifloxacin100%
    Part D27 patients
    Penicillins with extended spectrum0.8%
    Amoxicillin-Clavulanate Potass100%
    Part D19 patients

    + 2 more classes in this area

Where care is delivered (Part B)1.2% facility · 98.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”